Literature DB >> 22270277

A 20-year follow-up of young women with polycystic ovary syndrome.

Enrico Carmina1, Anna Maria Campagna, Roger A Lobo.   

Abstract

OBJECTIVE: To determine whether hormonal, metabolic, and anthropomorphic parameters change over 20 years in women with polycystic ovary syndrome (PCOS).
METHODS: One hundred ninety-three women with PCOS, aged 20-25 years, were diagnosed according to Rotterdam criteria, divided into four phenotypes (A-D), and followed at 5-year intervals for 20 years. Androgens, gonadotropins, insulin, glucose, body mass index, waist circumference, and ovarian volume were measured.
RESULTS: At diagnosis, 57% had classic features (phenotype A), 9% had classic features without ovarian findings (phenotype B), 26% had the ovulatory phenotype (C), and 7% were nonhyperandrogenic (D). After 10 years, androgens decreased (P<.05); at 15 years, waist circumference increased (P<.05); at 20 years, ovarian volume decreased (P<.01). Serum luteinizing hormone and follicle-stimulating hormone decreased nonsignificantly and fasting insulin and quantitative insulin-sensitivity check index were unchanged. Eighty-five women (44%) were ovulatory at 20 years, and 18 women (8%) could no longer be diagnosed as having PCOS.
CONCLUSION: After 20 years of follow-up in women with PCOS, androgens and ovarian volume decreased and there were more ovulatory cycles suggesting a milder disorder, whereas metabolic abnormalities persisted and waist circumference increased. LEVEL OF EVIDENCE: II.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22270277     DOI: 10.1097/AOG.0b013e31823f7135

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  30 in total

1.  Ovarian markers and irregular menses among women with type 1 diabetes in the Epidemiology of Diabetes Interventions and Complications study.

Authors:  C Kim; R S Miller; B H Braffett; Y Pan; V L Arends; A K Saenger; A Barnie; A V Sarma
Journal:  Clin Endocrinol (Oxf)       Date:  2018-01-26       Impact factor: 3.478

2.  Nesfatin-1 and other hormone alterations in polycystic ovary syndrome.

Authors:  Rulin Deniz; Bilgin Gurates; Suleyman Aydin; Husnu Celik; Ibrahim Sahin; Yakup Baykus; Zekiye Catak; Aziz Aksoy; Cihan Citil; Sami Gungor
Journal:  Endocrine       Date:  2012-02-25       Impact factor: 3.633

Review 3.  Ontogeny of polycystic ovary syndrome and insulin resistance in utero and early childhood.

Authors:  David H Abbott; Fida Bacha
Journal:  Fertil Steril       Date:  2013-07       Impact factor: 7.329

4.  Increased androgen, anti-Müllerian hormone, and sporadic anovulation in healthy, eumenorrheic women: a mild PCOS-like phenotype?

Authors:  Lindsey A Sjaarda; Sunni L Mumford; Kerri Kissell; Karen C Schliep; Ahmad O Hammoud; Neil J Perkins; Jennifer Weck; Jean Wactawski-Wende; Enrique F Schisterman
Journal:  J Clin Endocrinol Metab       Date:  2014-02-28       Impact factor: 5.958

Review 5.  Androgens and Hypertension in Men and Women: a Unifying View.

Authors:  Costanzo Moretti; Giulia Lanzolla; Marta Moretti; Lucio Gnessi; Enrico Carmina
Journal:  Curr Hypertens Rep       Date:  2017-05       Impact factor: 5.369

Review 6.  Ontogeny of the ovary in polycystic ovary syndrome.

Authors:  Daniel A Dumesic; Joanne S Richards
Journal:  Fertil Steril       Date:  2013-03-06       Impact factor: 7.329

Review 7.  The Relationship Between Polycystic Ovarian Syndrome, Periodontal Disease, and Osteoporosis.

Authors:  Hannah E Young; Wendy E Ward
Journal:  Reprod Sci       Date:  2020-09-10       Impact factor: 3.060

8.  Hyperandrogenic oligomenorrhea and metabolic risks across menopausal transition.

Authors:  Alex J Polotsky; Amanda A Allshouse; Sybil L Crawford; Sioban D Harlow; Naila Khalil; Rasa Kazlauskaite; Nanette Santoro; Richard S Legro
Journal:  J Clin Endocrinol Metab       Date:  2014-02-11       Impact factor: 5.958

9.  Clinical review: Lifecycle of polycystic ovary syndrome (PCOS): from in utero to menopause.

Authors:  Corrine K Welt; Enrico Carmina
Journal:  J Clin Endocrinol Metab       Date:  2013-09-24       Impact factor: 5.958

Review 10.  Longterm management of Polycystic Ovarian Syndrome (PCOS).

Authors:  Gordon W Bates; Richard S Legro
Journal:  Mol Cell Endocrinol       Date:  2012-12-20       Impact factor: 4.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.